News
The latest news from across neurorehabilitation.
News15 JanA new study, using long-term data adds to a growing evidence base linking air pollution with increased risk of dementia and stroke.
Researchers collected health data on more than 413,000 people taking part in the UK Biobank project.
News15 JanNew research for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer’s disease, to a type of brain cancer known as glioma.
The study, from Oregon Health & Science University, is published in the journal Nature Neuroscience.
News15 JanNew research provides insight into the severe and incurable form of brain cancer, glioblastoma, and potential therapies to combat treatment resistance.
Brain injury11 JanIn an early new year boost for Calvert Reconnections, case managers and NHS clinicians throughout the UK have praised the centre’s “life-changing” approach to ABI rehabilitation. Following recent experience days and visits to the Keswick-based residential centre, a range of brain injury professionals have shared their thoughts. “Calvert Reconnections is an amazing place,” said Jamie [...]
News10 JanThere's no better time to look for new opportunities than the beginning of a new year. NR Times Jobs has all the latest jobs from across the neuro and spinal injury rehab space. Here are our picks from the past week. Rehabilitation Case Manager (Remote) We are looking for Rehabilitation Field Case Managers, with [...]
Parkinson's10 JanResearchers have discovered that a protein called phosphorylated α-synuclein, which is associated with several neurodegenerative diseases such as Parkinson’s and Lewy body dementia, is also involved in the normal processes of how neurons communicate with each other in a healthy brain. Phosphorylation is a process where a phosphate ion is added to a specific amino [...]
Tech & industry10 JanThe value of the global market for rehab robotics is expected to more than quadruple between 2022 and 2030, data suggests. Kings Research reports that the market was recorded at US$239.1m in 2022, with growth likely to take it to US$1026.2m by 2030. As the world's population continues to grow and the field of robotics and AI advances, [...]
News9 JanPharma firm AbbVie has announced the launch in the European Union of Parkinson’s treatment Produodopa.
The product is use for the treatment of advanced Parkinson's with severe motor fluctuations and hyperkinesia (excessive movement) or dyskinesia (involuntary movement), and when available combinations of Parkinson's medicinal products have not given satisfactory results. PRODUODOPA is the first subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations in people living with advanced Parkinson's disease whose symptoms are inadequately controlled by other therapies.
Stroke9 JanA US university has developed a new robotic platform, which utilises a patient’s brainwaves and muscle activity, to enable post-stroke rehab.
The assistive planar robot includes a closed-loop feedback system to monitor the muscle and brain activity of the user in order to trigger the execution of reach and grab in an adaptive way.
In a new paper, researchers at the University of Rhode Island Motor Control and Rehabilitation lab write: “Numerous rehabilitation approaches such as muscular electrical stimulations, brain-computer interfaces, and transcranial magnetic stimulation have been investigated to assist the affected individuals.
